Gene therapy targets in heart failure: the path to translation
Heart failure (HF) is the common end point of cardiac diseases. Despite the optimization of therapeutic strategies and the consequent overall reduction in HF-related mortality, the key underlying intracellular signal transduction abnormalities have not been addressed directly. In this regard, the ga...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 August 2011
|
| In: |
Clinical pharmacology & therapeutics
Year: 2011, Jahrgang: 90, Heft: 4, Pages: 542-553 |
| ISSN: | 1532-6535 |
| DOI: | 10.1038/clpt.2011.148 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/clpt.2011.148 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1038/clpt.2011.148 
|
| Verfasserangaben: | P.W.J. Raake, H. Tscheschner, J. Reinkober, J. Ritterhoff, H.A. Katus, W.J. Koch, P. Most |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1816275735 | ||
| 003 | DE-627 | ||
| 005 | 20230710120520.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220908s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/clpt.2011.148 |2 doi | |
| 035 | |a (DE-627)1816275735 | ||
| 035 | |a (DE-599)KXP1816275735 | ||
| 035 | |a (OCoLC)1389792943 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Raake, Philip |d 1975- |e VerfasserIn |0 (DE-588)129151246 |0 (DE-627)390021725 |0 (DE-576)297510568 |4 aut | |
| 245 | 1 | 0 | |a Gene therapy targets in heart failure |b the path to translation |c P.W.J. Raake, H. Tscheschner, J. Reinkober, J. Ritterhoff, H.A. Katus, W.J. Koch, P. Most |
| 264 | 1 | |c 24 August 2011 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 08.09.2022 | ||
| 520 | |a Heart failure (HF) is the common end point of cardiac diseases. Despite the optimization of therapeutic strategies and the consequent overall reduction in HF-related mortality, the key underlying intracellular signal transduction abnormalities have not been addressed directly. In this regard, the gaps in modern HF therapy include derangement of β-adrenergic receptor (β-AR) signaling, Ca2+ disbalances, cardiac myocyte death, diastolic dysfunction, and monogenetic cardiomyopathies. In this review we discuss the potential of gene therapy to fill these gaps and rectify abnormalities in intracellular signaling. We also examine current vector technology and currently available vector-delivery strategies, and we delineate promising gene therapy structures. Finally, we analyze potential limitations related to the transfer of successful preclinical gene therapy approaches to HF treatment in the clinic, as well as impending strategies aimed at overcoming these limitations. Clinical Pharmacology & Therapeutics (2011) 90 4, 542-553. doi:10.1038/clpt.2011.148 | ||
| 700 | 1 | |a Tscheschner, Henrike |e VerfasserIn |0 (DE-588)1080316191 |0 (DE-627)844203033 |0 (DE-576)453478301 |4 aut | |
| 700 | 1 | |a Reinkober, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ritterhoff, Julia |e VerfasserIn |0 (DE-588)1043976426 |0 (DE-627)771174101 |0 (DE-576)396460941 |4 aut | |
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Koch, W. J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Most, Patrick |d 1969- |e VerfasserIn |0 (DE-588)124606431 |0 (DE-627)363440267 |0 (DE-576)29440919X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical pharmacology & therapeutics |d Hoboken, NJ : Wiley-Blackwell, 1960 |g 90(2011), 4, Seite 542-553 |h Online-Ressource |w (DE-627)325793247 |w (DE-600)2040184-X |w (DE-576)094531668 |x 1532-6535 |7 nnas |a Gene therapy targets in heart failure the path to translation |
| 773 | 1 | 8 | |g volume:90 |g year:2011 |g number:4 |g pages:542-553 |g extent:12 |a Gene therapy targets in heart failure the path to translation |
| 856 | 4 | 0 | |u https://doi.org/10.1038/clpt.2011.148 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1038/clpt.2011.148 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220908 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 124606431 |a Most, Patrick |m 124606431:Most, Patrick |d 910000 |d 910100 |e 910000PM124606431 |e 910100PM124606431 |k 0/910000/ |k 1/910000/910100/ |p 7 |y j | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |e 910000PK108916618 |e 910100PK108916618 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1043976426 |a Ritterhoff, Julia |m 1043976426:Ritterhoff, Julia |p 4 | ||
| 998 | |g 1080316191 |a Tscheschner, Henrike |m 1080316191:Tscheschner, Henrike |d 910000 |d 910100 |e 910000PT1080316191 |e 910100PT1080316191 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 129151246 |a Raake, Philip |m 129151246:Raake, Philip |d 910000 |d 910100 |e 910000PR129151246 |e 910100PR129151246 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1816275735 |e 4185767153 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Philip","role":"aut","display":"Raake, Philip","family":"Raake"},{"given":"Henrike","role":"aut","family":"Tscheschner","display":"Tscheschner, Henrike"},{"display":"Reinkober, J.","family":"Reinkober","role":"aut","given":"J."},{"display":"Ritterhoff, Julia","family":"Ritterhoff","given":"Julia","role":"aut"},{"display":"Katus, Hugo","family":"Katus","role":"aut","given":"Hugo"},{"family":"Koch","display":"Koch, W. J.","role":"aut","given":"W. J."},{"display":"Most, Patrick","family":"Most","given":"Patrick","role":"aut"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"24 August 2011","dateIssuedKey":"2011"}],"note":["Gesehen am 08.09.2022"],"title":[{"title_sort":"Gene therapy targets in heart failure","subtitle":"the path to translation","title":"Gene therapy targets in heart failure"}],"id":{"doi":["10.1038/clpt.2011.148"],"eki":["1816275735"]},"recId":"1816275735","relHost":[{"corporate":[{"role":"isb","display":"American Society for Clinical Pharmacology and Therapeutics"},{"role":"isb","display":"American Society for Pharmacology and Experimental Therapeutics"}],"language":["eng"],"titleAlt":[{"title":"CPT"},{"title":"Clinical pharmacology and therapeutics"}],"part":{"volume":"90","extent":"12","year":"2011","pages":"542-553","issue":"4","text":"90(2011), 4, Seite 542-553"},"origin":[{"publisher":"Wiley-Blackwell ; Mosby ; Nature Publ. Group","dateIssuedKey":"1960","dateIssuedDisp":"1960-","publisherPlace":"Hoboken, NJ ; St. Louis, Mo. ; Basingstoke"}],"note":["Gesehen am 18.02.2016"],"pubHistory":["1.1960 -"],"title":[{"title":"Clinical pharmacology & therapeutics","title_sort":"Clinical pharmacology & therapeutics","subtitle":"CPT ; official publication of the American Society for Clinical Pharmacology and Therapeutics and the American Society for Pharmacology and Experimental Therapeutics"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Gene therapy targets in heart failure the path to translationClinical pharmacology & therapeutics","physDesc":[{"extent":"Online-Ressource"}],"recId":"325793247","id":{"eki":["325793247"],"issn":["1532-6535"],"zdb":["2040184-X"],"doi":["10.1002/(ISSN)1532-6535"]}}],"name":{"displayForm":["P.W.J. Raake, H. Tscheschner, J. Reinkober, J. Ritterhoff, H.A. Katus, W.J. Koch, P. Most"]},"physDesc":[{"extent":"12 S."}]} | ||
| SRT | |a RAAKEPHILIGENETHERAP2420 | ||